Promensil

an isoflavone tablet providing 26 mg biochanin A, 16 mg formononetin, 1 mg genistein and 0.5 mg daidzein derived from red clover

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Hot Flashes 07/09/2003 - "Although the study provides some evidence for a biological effect of Promensil, neither supplement had a clinically important effect on hot flashes or other symptoms of menopause." 07/15/2004 - "Two hundred and fifty-two menopausal women ages 45-60 years experiencing > or =35 hot flashes per week were randomly assigned to Promensil (82 mg total isoflavones), Rimostil (57.2 mg total isoflavones), or placebo. " 07/09/2003 - "In comparison with the placebo group, participants in the Promensil group (41%; 95% confidence interval [CI], 29%-51%; P =.03), but not in the Rimostil group (34%; 95% CI, 22%-46%; P =.74) reduced hot flashes more rapidly. "
2.	Insulin Resistance 04/01/2012 - "The participants were randomized to one of four groups: 0.05 mg or 0.1 mg transdermal oestrogen/day, or 40 or 80 mg oral phytoestrogen (Promensil)/day insulin sensitivity was indirectly measured using the quantitative insulin sensitivity check index (QUICKI). "
3.	Breast Neoplasms (Breast Cancer) 03/01/2008 - "To assess the safety and tolerability of a standardized 40 mg red clover isoflavone dietary supplement (Promensil, Novogen) in women with a family history of breast cancer to evaluate the feasibility of using the supplement for prevention of breast cancer in healthy women. "

1.	Isoflavones
2.	Phytoestrogens (Phytoestrogen)
3.	CI 22